Catheterization and Cardiovascular Interventions · 2010 · 34 citations · 13 references
MedicineOrthopedic SurgerySurgeryOrthopedicsPerioperative SafetyVascular SurgeryLower Extremity RevascularizationOrbital SurgeryPeripheral Arterial InterventionVascular Access SafetyAnkle-brachial Index AssessmentFemoral-popliteal DiseaseOrbital AtherectomyPeripheral Arterial Disease InterventionPrimary Efficacy EndpointsSafety Endpoint AnalysisSafety Endpoint AssessmentTarget Lesion Revascularization
BACKGROUND: Plaque-debulking technologies have been proposed as alternative treatment options for peripheral arterial disease. Orbital atherectomy (OA), using the DiamondBack360 device, has emerged as one promising modality. METHODS: We evaluated the safety and efficacy of OA in the first 200 lesions treated at our institution. Patient demographics, clinical characteristics, and lesion and procedural variables were collected and analyzed. The primary safety endpoint was the 30-day major adverse events (MAE), including death, myocardial infarction, stroke, unplanned amputation, or target lesion revascularization. Other safety endpoints included access-site complications, occurrence of dissections, perforations, distal embolization, spasm, and hemolysis. The efficacy endpoints were procedural success, need for adjunctive therapy, and improvement in ankle-brachial index. Multivariate analysis was performed to find independent predictors of the safety endpoints. RESULTS: One hundred seventeen (58.5%) lesions were femoral, 31 (15.5%) were popliteal, and 52 (26.0%) were tibial. The procedural success (residual stenosis ≤30%) was comparable between the femoral and tibial lesions (86.3% vs. 92.5%, P = 0.18), but significantly lower for the popliteal lesions when compared with femoral and tibial (64.7% vs. 86.3%, P = 0.058, and 64.7% vs. 92.5%, P = 0.007 respectively). MAE at 30-days occurred in 3 (2.2%) procedures, and major access-site complications also occurred in 3 (2.2%). There were 31 (15.5%) dissections; independent predictors were diabetes mellitus (OR: 7.3, P = 0.008), crown-to-RVD ratio <0.6 (OR: 11.6, P = 0.005), and atherectomy time >360 sec (OR: 11.8, P = 0.001). There were 2 (1.0%) distal embolizations, 6 (3.0%) arterial spasms, and no perforations. Laboratory evidence of hemolysis was noted in 33.8% of cases. CONCLUSION: Orbital atherectomy allows for a significant procedural success, limited need for stenting, and favorable safety profile.
13
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Lars Norgren, William R. Hiatt, John Dormandy et al. · Journal of Vascular Surgery · 2007 · 8.2K citations · Full text
Medicine, Cardiology, Surgery +15
Universal Definition of Myocardial Infarction
Kristian Thygesen, Joseph S. Alpert, Harvey D. White · Circulation · 2007 · 4.2K citations
Alan T. Hirsch, Ziv J. Haskal, Norman Hertzer et al. · Journal of the American College of Cardiology · 2006 · 1K citations
Medicine, Cardiology, Surgery +17